Glatt Pharmaceutical Services – CDMO unlimited
COMPANY PROFILE
Glatt Pharmaceutical Services, with CDMO expertise dating back to 1975, provides comprehensive solutions for the formulation and process development of solid dosage forms.
Description
Glatt Pharmaceutical Services supports pharmaceutical and biotech companies through every stage of drug product development, from initial formulation design to large-scale commercial manufacturing. With expertise spanning early-stage development, including preclinical and clinical supply production, Glatt ensures seamless scalability while maintaining stringent quality standards. Leveraging advanced technologies like fluidized bed systems, spray granulation, and Wurster coating, Glatt specializes in creating tailored solutions for solubility enhancement, modified release, and other complex drug delivery challenges. Partnering with Glatt means access to end-to-end solutions designed to streamline the path from innovation to market.
Type of Drugs Manufactured:
Small Molecule
CDMO Services:
Drug Product Formulation (FDF);Research & Development;Clinical Trials materials and logistics;Analytical Development
No. of Manufacturing Facilities:
2
High Potent Products capabilities:
OEB 3;OEB 4-5
Facilities Locations:
Europe;North America
Regulatory Approvals for facilities:
FDA (United States);EMA (Europe);GMP
Manufacturing Technologies:
Solids
Current Capacity:
We have main capacities in the formulatio, process development and clinical manufacturing incl. clinical supply services such as labeling, packaging, placebo manufacturing, etc.








